SCHEMBL25311650

SCHEMBL25311650

CC(C)n1cnc2c(NCc3ccc(-c4cccnc4)nc3)nc(Cl)nc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 12/20 0.64
CDK2 P24941 16/20 0.59
CCNA2 P20248 3/20 0.59
CCNA1 P78396 3/20 0.59
CDK5 Q00535 2/20 0.59
DYRK1A Q13627 1/20 0.59
CDK5R1 Q15078 1/20 0.59
CDK9 P50750 6/20 0.57
CCNK O75909 3/20 0.56
CDK12 Q9NYV4 3/20 0.56
CCNE1 P24864 12/20 0.55
CCNE2 O96020 2/20 0.55
CDK4 P11802 11/20 0.54
CDK7 P50613 11/20 0.54
MAPK1 P28482 10/20 0.54
CCNH P51946 10/20 0.54
CCNB1 P14635 9/20 0.54
CCND1 P24385 9/20 0.54
CCNT1 O60563 4/20 0.54
MNAT1 P51948 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30518535 0.90 CCNK (0.64) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25308297 0.90 CCNK (0.64) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25308752 0.90 CCNK (0.68) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25861947 0.89 CDK2 (0.57) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL3859252 0.88 CDK1 (0.78) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25308887 0.88 CCNK (0.60) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL30518552 0.88 CCNK (0.60) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL30518562 0.87 CCNK (0.59) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25309290 0.87 CCNK (0.59) CDK1CDK2CCNA2CCNA1CDK5
SCHEMBL25309513 0.87 CDK2 (0.62) CDK1CDK2CCNA2CCNA1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101023-A1 HETEROARYL DERIVATIVE AND USES THEREOF IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2025-03-27 US disclosed
WO-2023140640-A1 HETEROARYL DERIVATIVE AND USES THEREOF 한양대학교 산학협력단 2023-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101023-A1 HETEROARYL DERIVATIVE AND USES THEREOF ERBB2, ERBB3, FGFR2 CDK1 2784/4885CDK2 79/4885CCNA2 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.